NEW YORK, Feb. 16, 2018 /PRNewswire/ -- DFB Healthcare
Acquisitions Corp. ("DFB Healthcare") announced today that it has
priced its initial public offering of 25,000,000 units at
$10.00 per unit. The units will be
listed on the NASDAQ Capital Market and trade under the ticker
symbol "DFBHU" beginning today. Each unit consists of one share of
the Company common stock and one-third of one warrant, each whole
warrant enabling the holder thereof to purchase one share of common
stock at a price of $11.50 per
share. No fractional warrants will be issued upon separation
of the units and only whole warrants will trade.
DFB Healthcare is being sponsored by Deerfield/RAB Ventures, LLC, which was jointly
founded by Deerfield Management Company L.P. ("Deerfield") and DFB Healthcare's management
team, led by CEO Richard Barasch.
Deerfield is an investment firm
focused exclusively on the healthcare industry, and its investment
activity spans both public and private securities. Mr. Barasch has
more than 30 years of experience in healthcare services, health
insurance, and related industries, and was CEO of Universal
American Corp. from 1995 until the Company's acquisition by
WellCare Health Plans in April 2017.
Goldman Sachs & Co. and Deutsche Bank Securities are acting
as joint book runners for the offering and Leerink Partners is
acting as co-manager. DFB Healthcare has granted the underwriters a
45-day option to purchase up to an additional 3,750,000 units at
the initial public offering price to cover over-allotments, if
any.
A registration statement relating to these securities has been
filed with, and declared effective by, the Securities and Exchange
Commission on February 15, 2018. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction. The registration statement can be obtained
at www.sec.gov.
About DFB Healthcare Acquisitions Corp.
DFB Healthcare Acquisitions Corp. is a newly organized blank
check company formed for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses. It has
not identified any business combination target and has not, nor has
anyone on its behalf, initiated any substantive discussions,
directly or indirectly, with respect to identifying any business
combination target. Its acquisition and value creation strategy
will be to identify and acquire a business in the healthcare
sector.
The offering is being made only by means of a prospectus. Copies
of the prospectus related to the offering may be obtained, when
available, from Goldman, Sachs & Co., Attention: Prospectus
Department, 200 West Street, New York,
NY 10282, or by telephone toll-free at 1-866-471-2526 or by
email at prospectus-ny@ny.email.gs.com, from Deutsche Bank
Securities Inc., Attention: Prospectus Group, 60 Wall Street,
New York, New York 10005-2836
(Tel: (800) 503-4611; Email: prospectus.CPDG@db.com), and from
Leerink Partners LLC, Attention: Syndicate Department, One Federal
Street, 37th Floor, Boston, MA
02110, by telephone at 800-808-7525, ext. 6132 or by email at
syndicate@leerink.com.
Contact
DFB Healthcare Acquisitions Corp.
Chris Wolfe, (212) 965-2400
cwolfe@rabventuresllc.com
View original
content:http://www.prnewswire.com/news-releases/dfb-healthcare-acquisitions-corp-announces-pricing-of-250-million-initial-public-offering-300600297.html
SOURCE DFB Healthcare Acquisitions Corp.